COGT•benzinga•
JP Morgan Maintains Overweight on Cogent Biosciences, Raises Price Target to $25
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 29, 2025 by benzinga